Business
AXIM® Biotechnologies, Inc. Announces Attendance and Presentation by Chief Technology Officer Lekhram Changoer at Kannaway® “Believe” National Convention
AXIM® Biotechnologies, Inc. Announces Attendance and Presentation by Chief Technology Officer Lekhram Changoer at Kannaway® “Believe” National Convention.
About this update from Axim Biotechnologies, Inc.
[{"type":"text","content":"\nNEW YORK, April 12, 2019 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (“AXIM”) (“the Company”) (“AXIM® Biotech”) (OTC: AXIM), a world leader in cannabinoid research and development, today announced the company’s Chief Technology Officer Lekhram Changoer will be speaking at the “Believe” National Convention held by Kannaway®, the first hemp lifestyle network to offer cannabidiol (“CBD”) hemp botanical products, on April 13, 2019 in San Diego.\n Changoer will present on the science behind the company’s chewing gum as an effective delivery mechanism for cannabinoids, CBD in particular. AXIM's research has shown that its proprietary encapsulation methodology, combined with patented chewing gum delivery system, causes CBD to be effectively released from the chewing gum into the oral cavity to increase CBD presence for absorption through the oral mucosa. AXIM holds exclusive licenses to two patents on chewing gums containing cannabinoids, including CBD and tetrahydrocannabinol (“THC”). “We’re looking forward to the ‘Believe’ event and to educating the Kannaway community,” said Lekhram Changoer, Chief Technology Officer of AXIM® Biotech. “Our encapsulation technology gives us an opportunity to be a key player in the hemp market and Kannaway is a great partner to reach consumers who are interested in hemp and its wide-ranging benefits. I’m excited to share AXIM’s knowledge and key findings in chewing gum as a delivery mechanism for CBD.” In February 2019, Kannaway® announced a significant purchase order from AXIM® Biotech for CanChew+™, a cannabinoid-based chewing gum containing 50 mg of full-spectrum hemp oil and 10 mg of CBD per piece. “AXIM looks forward to expanding the reach of our consumer-directed product, CanChew+™, through this purchase order with Kannaway® as the company distributes to thousands of consumers around the world,” said John W. Huemoeller II, Chief Executive Officer of AXIM® Biotech. “We will now be able to reach more people interested in the benefits of hemp with our CBD gum.” To learn more about AXIM® Biotechnologies, Inc., visit http://aximbiotech.com/. About AXIM® BiotechnologiesAXIM...